{"id":46402,"date":"2022-07-20T22:01:55","date_gmt":"2022-07-20T20:01:55","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\/"},"modified":"2022-07-20T22:01:55","modified_gmt":"2022-07-20T20:01:55","slug":"clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\/","title":{"rendered":"Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8"},"content":{"rendered":"
\n

BOULDER, Colo.–(BUSINESS WIRE)–$CLVS<\/a>–Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its second quarter 2022 financial results and provide an update on its clinical development programs and regulatory and business outlook on Monday, August 8, 2022, before the open of the US financial markets. Clovis\u2019 senior management will host a conference call and live audio webcast at 6:30am ET to discuss Clovis\u2019 results and business outlook in greater detail.\n<\/p>\n

\nThe conference call will be simultaneously webcast on the Clovis Oncology website www.clovisoncology.com<\/a>, and a replay of the webcast will be available for 30 days.\n<\/p>\n

<\/a><\/p>\n

\nDial-in numbers for the conference call are as follows: US participants 888.440.4615 International participants 646.960.0682, conference ID: 2259685.<\/b>\n<\/p>\n

\nAbout Clovis Oncology<\/b>\n<\/p>\n

\nClovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the US, Europe, and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops with partners diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado; please visit www.clovisoncology.com<\/a> for more information, including additional office locations in the US and Europe.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nClovis Investor Contacts:<\/b>
Anna Sussman
\n
303.625.5022
\n
asussman@clovisoncology.com<\/a>\n<\/p>\n

\nBreanna Burkart
\n
303.625.5023
\n
bburkart@clovisoncology.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BOULDER, Colo.–(BUSINESS WIRE)–$CLVS–Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its second quarter 2022 financial results and provide an update on its clinical development programs and regulatory and business outlook on Monday, August 8, 2022, before the open of the US financial markets. Clovis\u2019 senior management will host a conference call and live audio webcast at … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46402","6":"format-standard","7":"category-industry"},"yoast_head":"\nClovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BOULDER, Colo.–(BUSINESS WIRE)–$CLVS–Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its second quarter 2022 financial results and provide an update on its clinical development programs and regulatory and business outlook on Monday, August 8, 2022, before the open of the US financial markets. Clovis\u2019 senior management will host a conference call and live audio webcast at ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-20T20:01:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220720005107\/en\/305545\/21\/Clovis_Logo_Process_Color.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8\",\"datePublished\":\"2022-07-20T20:01:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\\\/\"},\"wordCount\":226,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220720005107\\\/en\\\/305545\\\/21\\\/Clovis_Logo_Process_Color.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\\\/\",\"name\":\"Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220720005107\\\/en\\\/305545\\\/21\\\/Clovis_Logo_Process_Color.jpg\",\"datePublished\":\"2022-07-20T20:01:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220720005107\\\/en\\\/305545\\\/21\\\/Clovis_Logo_Process_Color.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220720005107\\\/en\\\/305545\\\/21\\\/Clovis_Logo_Process_Color.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\/","og_locale":"en_US","og_type":"article","og_title":"Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8 - Pharma Trend","og_description":"BOULDER, Colo.–(BUSINESS WIRE)–$CLVS–Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its second quarter 2022 financial results and provide an update on its clinical development programs and regulatory and business outlook on Monday, August 8, 2022, before the open of the US financial markets. Clovis\u2019 senior management will host a conference call and live audio webcast at ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-20T20:01:55+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220720005107\/en\/305545\/21\/Clovis_Logo_Process_Color.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8","datePublished":"2022-07-20T20:01:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\/"},"wordCount":226,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220720005107\/en\/305545\/21\/Clovis_Logo_Process_Color.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\/","url":"https:\/\/pharma-trend.com\/en\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\/","name":"Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220720005107\/en\/305545\/21\/Clovis_Logo_Process_Color.jpg","datePublished":"2022-07-20T20:01:55+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220720005107\/en\/305545\/21\/Clovis_Logo_Process_Color.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220720005107\/en\/305545\/21\/Clovis_Logo_Process_Color.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/clovis-oncology-to-announce-second-quarter-2022-financial-results-and-host-webcast-conference-call-on-august-8\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46402","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46402"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46402\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46402"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46402"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46402"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}